Veritas In Silico

IPO

ホーム | 株式会社 Veritas In Silico

Veritas In Silico is headquartered in Tokyo, Japan, lists 11–50 employees, and has 1 recorded funding round.

Headquarters
Tokyo
Employees
11–50
Business Model
B2B
Last Round
SeedMay 2017
Rounds
1
Type
Public

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Veritas In Silico is a Tokyo-based AI drug discovery company specializing in small molecule drugs that target RNA. Using its proprietary AI platform and the AISLAR screening methodology, the company identifies and designs small molecules capable of binding to mRNA structures, enabling novel therapeutic approaches for cancer, genetic diseases, and other conditions. Listed on the Tokyo Stock Exchange Growth Market in February 2024, Veritas In Silico has established co-discovery partnerships with major pharmaceutical companies including Takeda, Shionogi, Toray, Asahi Kasei Pharma, and Mitsubishi Gas Chemical.

Summary

Veritas In Silico is an Artificial Intelligence company based in Tokyo, Japan. It lists 11–50 employees. Its most recent funding was a Seed round in May 2017.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOFeb 2024

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Veritas In Silico on Indexed.vc
<a href="https://indexed.vc/companies/veritas-in-silico"><img src="https://indexed.vc/api/badge/company/veritas-in-silico" alt="Veritas In Silico on Indexed.vc" width="260" height="76" /></a>